Endovascular
Drug-eluting coatings for implants (e.g., stents)
DevelopmentActive
Key Facts
Indication
Drug-eluting coatings for implants (e.g., stents)
Phase
Development
Status
Active
Company
About TheraDep Technologies
TheraDep Technologies is a private, early-stage company developing a proprietary dry-coating platform based on Cold Atmospheric Plasma (CAP) technology. Their BioDep™ process enables the covalent bonding of proteins, peptides, and pharmaceuticals to surfaces like metals, polymers, and ceramics without heat or chemical binders, preserving biomolecule integrity. The company targets four primary verticals: functionalized microplates for assays, coated medical devices, drug-eluting endovascular implants, and scalable coating systems for manufacturing integration. As a platform technology provider, TheraDep is positioned in the high-growth drug delivery and advanced medical coatings sector.
View full company profile